Fundraising FoxAdaptamtx
San Sebastián, ES · 1 known investors
Find your way into Adaptamtx
Sign up to see every warm intro you have to Adaptamtx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Adaptamtx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Adaptam Therapeutics develops antibody-based cancer immunotherapies, including antibody-drug conjugates and bispecific antibodies, that target the immunosuppressive myeloid tumor microenvironment via novel targets such as glycan-binding proteins and Siglecs. A spin-off from CIC bioGUNE, the company serves oncology patients and is developing first-in-class therapies for multiple cancer indications.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Adaptamtx do?
- Adaptam Therapeutics develops antibody-based cancer immunotherapies, including antibody-drug conjugates and bispecific antibodies, that target the immunosuppressive myeloid tumor microenvironment via novel targets such as glycan-binding proteins and Siglecs. A spin-off from CIC bioGUNE, the company serves oncology patients and is developing first-in-class therapies for multiple cancer indications.
- Who founded Adaptamtx?
- Adaptamtx was founded by Asis Palazon.
- Who are Adaptamtx's investors?
- Adaptamtx's investors include Criteria Bio Ventures.
- Where is Adaptamtx headquartered?
- Adaptamtx is headquartered in San Sebastián, ES.